Daré Bioscience's Q4 2024 earnings highlight a dual-path strategy for Sildenafil Cream, targeting 2025 revenue with 503B compounding while advancing ...

The company projects initial revenue generation from its Sildenafil Cream formulation in Q4 2025, backed by its 503B compounding strategy. Daré plans to provide updates in Q2 2025 on strategic ...

Q4 2024 Earnings Call Transcript March 31, 2025 Daré Bioscience, Inc. beats earnings expectations. Reported EPS is $-0.61, ...

With increasing demand for needed treatments designed for women, Daré is taking action to make its proprietary Sildenafil ...

Experts warn that ExtenZe may not be safe to use for erectile dysfunction. Read on to find out why and to learn about its ...

Welcome to the conference call hosted by Dare Bioscience to review the company's 2024 financial results and to provide a business update. This call is being recorded. My name is Jericho, and I'll be ...

When a pair of young Thai masseuses arrived at Shane Warne's hotel room in 2022, they had no idea they'd be the last people ...

Several observations from preclinical and short-term clinical studies support a role for sildenafil in the treatment of heart failure patients. The following discussion briefly considers each of ...

Shane Warne passed away in March 2022, and after three years, some shocking details have grabbed the attention out of nowhere ...

The medical report of Shane Warne’s death has come to light for the first time three years after the cricket icon’s death.

New details have recently surfaced about the sudden death of cricket legend Shane Warne, shedding more light on what happened ...